| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 46 |
| 1 | DEXAMETHASONE | 37 |
| 2 | DEXAMETHASONE 1.5 MG | 37 |
| 3 | ACETAMINOPHEN | 34 |
| 4 | ACETAMINOPHEN 500MG | 30 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 30 |
| 6 | BISOPROLOL FUMARATE | 30 |
| 7 | PAIN RELIEVER | 30 |
| 8 | PROPOFOL | 28 |
| 9 | RAMIPRIL | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEFLOQUINE HYDROCHLORIDE | 7 | 0.0449 |
| 1 | METHAMPHETAMINE HYDROCHLORIDE | 3 | 0.0028 |
| 2 | IDARUBICIN HYDROCHLORIDE | 2 | 0.0017 |
| 3 | TEBENTAFUSP | 1 | 0.0017 |
| 4 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 5 | ATRACURIUM BESYLATE | 1 | 0.0014 |
| 6 | CYCLOSERINE | 3 | 0.0013 |
| 7 | FENOFIBRIC ACID | 1 | 0.0013 |
| 8 | MEBENDAZOLE | 1 | 0.0013 |
| 9 | NADOLOL | 9 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 79 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 57 |
| 2 | Loop Diuretic [EPC] | 48 |
| 3 | Benzodiazepine [EPC] | 33 |
| 4 | Platinum-based Drug [EPC] | 31 |
| 5 | General Anesthetic [EPC] | 30 |
| 6 | Kinase Inhibitor [EPC] | 28 |
| 7 | Aromatase Inhibitor [EPC] | 27 |
| 8 | Aldosterone Antagonist [EPC] | 26 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 3 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 4 | Actinomycin [EPC] | 2 | 0.0009 |
| 5 | Antiparasitic [EPC] | 4 | 0.0009 |
| 6 | Pediculicide [EPC] | 4 | 0.0008 |
| 7 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 8 | General Anesthetic [EPC] | 30 | 0.0007 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |